Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...
Of the patients enrolled, 440 completed the placebo run-in phase and were randomized to receive treatment with either amlodipine (n=218) or losartan (n=222). One hundred nineteen patients ...